Brendan Egan is President of North America at nuaxia. With over twenty years of sales and market research experience, conducting both quantitative and qualitative methodologies, Brendan’s responsible for the growing the nuaxia business among the North America client base. Before joining nuaxia, Brendan was Head of Corporate Markets at Coleman Research and President of Business development at Medefield. During his 8-year tenure at Medefield, he more than doubled the size of the business. Prior to this, he held senior roles at Lightspeed Research and Harris Interactive, where he specialized in managing studies to support pharmaceutical launches.